For adults with severe scabies, higher-dose ivermectin plus permethrin is not superior to standard-dose ivermectin plus permethrin, according to a study published in the New England Journal of ...
In a recent study published in JAMA, researchers evaluate the efficacy of ivermectin in a maximum dosage of 600 μg/kg/day over six days in treating early mild-to-moderate coronavirus disease 2019 ...
Ivermectin, the anti-parasitic medication most commonly used as a dewormer in animals, is back in the limelight. This time it has nothing to do with COVID-19.
The drug has not been found to be effective against cancer, experts say.
SEATTLE -- A higher dose of ivermectin given for a longer duration still failed to offer any benefit in mild to moderate COVID-19, data from a large randomized U.S. trial showed. In the ACTIV-6 trial ...
Researchers conducted a blinded, randomized trial of 132 adults with confirmed severe scabies (profuse or crusted) between October 2017 and January 2025 in France. Participants were randomly assigned ...
A 400 μg/kg body weight plus 5% permethrin cream was found to be not superior to 200 μg/kg body weight plus permethrin. HealthDay News — For adults with severe scabies, higher-dose ivermectin plus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results